[{"Assets_0_Q3_USD":58369000.0,"CommonStockSharesOutstanding_0_Q3_shares":935040.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-29786000.0,"NetIncomeLoss_1_Q3_USD":-9971000.0,"NetIncomeLoss_3_Q3_USD":-29781000.0,"StockholdersEquity_0_Q3_USD":-124797000.0,"Ticker":"RAPT","CIK":"1673772","name":"RAPT THERAPEUTICS, INC.","OfficialName":"RAPT Therapeutics Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"595076458.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191211"}]